Cell permeable peptides for inhibition of inflammatory reactions and methods of use
CA 2391943 A1 · Owner: Vanderbilt University · Inventors: Collins, Robert D.; Timmons, Sheila; Veach, Ruth Ann
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the delivery of biologically active molecules, such as peptides, into the interior of cells by administering to the cells a complex comprising the molecule linked to an importation competent signal peptide. Such delivery can be utilized for example, to treat and/or , prevent inflammatory conditions e.g. but not limited to, systemic , inflammatory reactions such as endotoxic shock localized inflammatory , reactions such as inflammatory skin diseases and conditions and inflammatory , diseases such as autoimmune diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.